OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of gemigliptin, a dipeptidyl peptidase‐4 inhibitor, on lipid metabolism and endotoxemia after a high‐fat meal in patients with type 2 diabetes
Chang Ho Ahn, Eun Ky Kim, Se Hee Min, et al.
Diabetes Obesity and Metabolism (2016) Vol. 19, Iss. 3, pp. 457-462
Closed Access | Times Cited: 10
Chang Ho Ahn, Eun Ky Kim, Se Hee Min, et al.
Diabetes Obesity and Metabolism (2016) Vol. 19, Iss. 3, pp. 457-462
Closed Access | Times Cited: 10
Showing 10 citing articles:
Effect of Dietary Lipids on Endotoxemia Influences Postprandial Inflammatory Response
Javier López-Moreno, Sonia García‐Carpintero, Rosa Jiménez-Lucena, et al.
Journal of Agricultural and Food Chemistry (2017) Vol. 65, Iss. 35, pp. 7756-7763
Closed Access | Times Cited: 37
Javier López-Moreno, Sonia García‐Carpintero, Rosa Jiménez-Lucena, et al.
Journal of Agricultural and Food Chemistry (2017) Vol. 65, Iss. 35, pp. 7756-7763
Closed Access | Times Cited: 37
Pharmacology of dipeptidyl peptidase-4 inhibitors and its use in the management of metabolic syndrome: a comprehensive review on drug repositioning
Maryam Rameshrad, Bibi Marjan Razavi, Gordon A. Ferns, et al.
DARU Journal of Pharmaceutical Sciences (2019) Vol. 27, Iss. 1, pp. 341-360
Open Access | Times Cited: 32
Maryam Rameshrad, Bibi Marjan Razavi, Gordon A. Ferns, et al.
DARU Journal of Pharmaceutical Sciences (2019) Vol. 27, Iss. 1, pp. 341-360
Open Access | Times Cited: 32
The regulatory role of DPP4 in atherosclerotic disease
Lihua Duan, Xiaoquan Rao, Chang Xia, et al.
Cardiovascular Diabetology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 27
Lihua Duan, Xiaoquan Rao, Chang Xia, et al.
Cardiovascular Diabetology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 27
Impact of dipeptidyl-peptidase 4 inhibitors on cardiovascular diseases
Weijia Xie, Xiaoxiao Song, Zhenjie Liu
Vascular Pharmacology (2018) Vol. 109, pp. 17-26
Closed Access | Times Cited: 26
Weijia Xie, Xiaoxiao Song, Zhenjie Liu
Vascular Pharmacology (2018) Vol. 109, pp. 17-26
Closed Access | Times Cited: 26
Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial
Atsuko Chihara, Atsushi Tanaka, Takeshi Morimoto, et al.
Cardiovascular Diabetology (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 13
Atsuko Chihara, Atsushi Tanaka, Takeshi Morimoto, et al.
Cardiovascular Diabetology (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 13
Sitagliptin improves plasma apolipoprotein profile in type 2 diabetes: A randomized clinical trial of sitagliptin effect on lipid and glucose metabolism (SLIM) study
Kyoko Tanimura‐Inagaki, Mototsugu Nagao, Taro Harada, et al.
Diabetes Research and Clinical Practice (2020) Vol. 162, pp. 108119-108119
Closed Access | Times Cited: 9
Kyoko Tanimura‐Inagaki, Mototsugu Nagao, Taro Harada, et al.
Diabetes Research and Clinical Practice (2020) Vol. 162, pp. 108119-108119
Closed Access | Times Cited: 9
Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis
Shangyu Chai, Ruya Zhang, Ye Zhang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 4
Shangyu Chai, Ruya Zhang, Ye Zhang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 4
The Effects of Teneligliptin on Lipid Profile: A Prospective Study for Comparison of Biomarkers Before and After a Meal
Osamu Tomonaga, Masaki Kobayashi, Ryoma Tagawa, et al.
Journal of Endocrinology and Metabolism (2020) Vol. 10, Iss. 3-4, pp. 79-88
Open Access | Times Cited: 1
Osamu Tomonaga, Masaki Kobayashi, Ryoma Tagawa, et al.
Journal of Endocrinology and Metabolism (2020) Vol. 10, Iss. 3-4, pp. 79-88
Open Access | Times Cited: 1
Dipeptidyl Peptidase-4 Inhibitors and Cardiovascular Side Effects
Rizal Rizal, Suharjono Suharjono
Pharmaceutical Journal of Indonesia (2021) Vol. 6, Iss. 2, pp. 69-75
Open Access | Times Cited: 1
Rizal Rizal, Suharjono Suharjono
Pharmaceutical Journal of Indonesia (2021) Vol. 6, Iss. 2, pp. 69-75
Open Access | Times Cited: 1
Dipeptidyl Peptidase-4 Inhibitors
Yoo Hyung Kim, Young Min Cho
Stroke revisited (2021), pp. 143-154
Closed Access
Yoo Hyung Kim, Young Min Cho
Stroke revisited (2021), pp. 143-154
Closed Access
